Letter: diagnostic delay in inflammatory bowel disease-Authors' reply

Richard C Pollok^{1

2

3}, Samantha Baillie^{1

2

3}, Nishani Jayasooriya^{1

2

3}, Jonathan Blackwell^{1

2

3}, Irene Petersen^{4

5}, Alex Bottle³, Sonia Saxena³; POP-IBD Study Group

Affiliations

¹ Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.
² Institute of Infection and Immunity, St George's University, London, UK.
³ School of Public Health, Imperial College London, London, UK.
⁴ Department of Primary Care and Population Health, University College London, London, UK.
⁵ Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.

Comment

Richard C Pollok et al. Aliment Pharmacol Ther. 2023 May.

. 2023 May;57(10):1205-1206.

doi: 10.1111/apt.17493.

Richard C Pollok^{1

2

3}, Samantha Baillie^{1

2

3}, Nishani Jayasooriya^{1

2

3}, Jonathan Blackwell^{1

2

3}, Irene Petersen^{4

5}, Alex Bottle³, Sonia Saxena³; POP-IBD Study Group

¹ Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.
² Institute of Infection and Immunity, St George's University, London, UK.
³ School of Public Health, Imperial College London, London, UK.
⁴ Department of Primary Care and Population Health, University College London, London, UK.
⁵ Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.

No abstract available

Comment on

Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, Saxena S, Pollok RC; POP-IBD study group. Jayasooriya N, et al. Aliment Pharmacol Ther. 2023 Mar;57(6):635-652. doi: 10.1111/apt.17370. Epub 2023 Jan 10. Aliment Pharmacol Ther. 2023. PMID: 36627691
Letter: diagnostic delay in inflammatory bowel disease.
Tassone D, Gilmore R, Lee T, Ding NS. Tassone D, et al. Aliment Pharmacol Ther. 2023 May;57(10):1203-1204. doi: 10.1111/apt.17483. Aliment Pharmacol Ther. 2023. PMID: 37094304 No abstract available.

1. Tassone D, Gilmore R, Lee T, Ding NS. Letter: diagnostic delay in inflammatory bowel disease. Aliment Pharmacol Ther. 2023;1203-1204.
1. Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, et al. Systematic review with meta-analysis: time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Aliment Pharmacol Ther. 2023;57(6):635-52. https://doi.org/10.1111/apt.17370
1. Blackwell J, Saxena S, Jayasooriya N, Bottle A, Petersen I, Hotopf M, et al. Prevalence and duration of gastrointestinal symptoms before diagnosis of inflammatory bowel disease and predictors of timely specialist review: a population-based study. J Crohns Colitis. 2021;15(2):203-11. https://doi.org/10.1093/ecco-jcc/jjaa146
1. Herbert A, Rafiq M, Pham TM, Renzi C, Abel GA, Price S, et al. Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: a cohort study. PLOS Med. 2021;18(8):e1003708. https://doi.org/10.1371/journal.pmed.1003708
1. Crohn's and Colitis UK. Symptom checker. Accessed March 15, 2023 https://crohnsandcolitis.org.uk/our-work/campaigns/symptom-checker